美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

信息服务

4.12

-0.1400-3.29%

盘后：4.120.00000.00%16:33 EDT

成交量：16.88万

成交额：69.52万

市值：1.97亿

市盈率：19.62

高：4.26

开：4.26

低：4.06

收：4.26

52周最高：6.45

52周最低：3.74

股本：4,788.41万

流通股本：3,498.93万

量比：0.88

换手率：0.48%

股息：0.18

股息率：4.37%

每股收益(TTM):0.2100

每股收益(LYR):0.1900

净资产收益率：11.17%

总资产收益率：5.99%

市净率：2.09

市盈率(LYR):21.68

数据加载中...

总览公司新闻公告

信息服务业增势良好广东两业协同发展更有支撑

翰森制药(03692)：HS-20093治疗骨肉瘤III期临床研究达到主要终点

港股异动 | 乐普生物(02157)涨近4% CMG901全球III期临床试验CLARITY-GASTRIC01取得积极顶线结果

乐普生物：CMG901全球III期临床试验CLARITY-GASTRIC01达主要终点

南方财经网

康诺亚-B：CMG901全球III期临床获积极顶线结果，OS改善具统计学显著性

石药集团：盐酸阿姆西汀肠溶片III期临床试验达主要终点

南方财经网

Arrowhead完成Zodasiran全球III期YOSEMITE试验患者入组

环球市场播报

阿斯利康Sone-Ve在晚期胃癌III期试验中显著延长总生存期

环球市场播报

石药集团：盐酸阿姆西汀肠溶片III期临床试验达到主要终点

诺诚健华：ICP-488治疗银屑病III期试验达主要终点

南方财经网

百利天恒：伦康依隆妥单抗两项III期临床完成首例入组

百济神州/安进 FIC 双抗，皮下制剂进入 III 期

百利天恒：伦康依隆妥单抗III期临床试验完成首例受试者入组

远大医药(00512)：中药1.1类创新药GPN01360在中国开展的III期临床研究完成首例患者入组给药

Devonian获加拿大卫生部批准，启动Thykamine小儿特应性皮炎II/III期试验

环球市场播报

君实生物：特瑞普利单抗新适应症补充申请获受理拓展至II-III期可切除非小细胞肺癌

加科思-B(01167)：完成泛KRAS抑制剂JAB-23E73联合化疗用于KRAS突变胰腺癌一线治疗之Ib/III期临床试验在中国的首例患者给药

午评：创指低开低走大跌4.71% 下跌个股超4300只

中国电信云网发展部和政企信息服务事业群总经理调整

人民邮电报

科伦博泰TROP2 ADC实现“全球首个”：PD-L1阴性一线NSCLC III期达PFS主要终点

每日经济新闻

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/III/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"III","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","market":"US","secType":"STK","nameCN":"信息服务","latestPrice":4.12,"timestamp":1785441600000,"preClose":4.26,"halted":0,"volume":168845,"hourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"16:33 EDT","volume":3188,"amount":13134.56,"timestamp":1785443604567,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03286384976525814,"floatShares":34989300,"shares":47884104,"eps":0.209971,"marketStatus":"盘后交易","change":-0.14,"latestTime":"07-30 16:37:02 EDT","open":4.255,"high":4.255,"low":4.06,"amount":695236.0875775,"amplitude":0.045775,"askPrice":4.3,"askSize":100,"bidPrice":3.69,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.209971,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785456000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1171256400000,"exchange":"NASDAQ","adjPreClose":4.26,"dividendRate":0.043689,"preHourTrading":{"tag":"盘前","latestPrice":4.19,"preClose":4.26,"latestTime":"09:29 EDT","volume":136,"amount":574.3400088,"timestamp":1785418141106,"change":-0.07,"changeRate":-0.016432,"amplitude":0.049296},"postHourTrading":{"tag":"盘后","latestPrice":4.12,"preClose":4.12,"latestTime":"16:33 EDT","volume":3188,"amount":13134.56,"timestamp":1785443604567,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.877349,"impliedVol":1.7448,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"III\",,,,,undefined,":{"symbol":"III","floatShares":34989300,"roa":"5.99%","roe":"11.17%","lyrEps":0.19,"volumeRatio":0.877349,"shares":47884104,"dividePrice":0.18,"high":4.255,"amplitude":0.045775,"preClose":4.26,"low":4.06,"week52Low":3.74,"pbRate":"2.09","psRate":"0.80","week52High":6.4495,"institutionHeld":0.6684,"latestPrice":4.12,"eps":0.209971,"divideRate":0.043689,"volume":168845,"delay":0,"ttmEps":0.209971,"open":4.255,"prevYearClose":5.78,"prevWeekClose":3.86,"prevMonthClose":4.11,"prevQuarterClose":4.11,"fiveDayClose":3.84,"twentyDayClose":4.19,"sixtyDayClose":4.12,"earningDate":1785859200000,"earningTime":"盘后","dividendPayoutRate":0.9280598907982862,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.03333720106347336},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/III\",params:#limit:5,,,undefined,":[{"date":"2026-08-05","symbol":"III","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0.06,"defaultRemindTime":1785960000000,"name":null,"time":"盘后","dateTimestamp":1785902400000,"actualEps":null},{"date":"2026-06-05","symbol":"III","amount":0.045,"announcedDate":"2026-05-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-05","defaultRemindTime":1780666200000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-05","currency":"USD","dateTimestamp":1780632000000,"payDate":"2026-06-26"},{"market":"US","date":"2026-05-07","symbol":"III","fiscalQuarterEnding":"2026/03","expectedEps":0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":0.06},{"date":"2026-03-20","symbol":"III","amount":0.045,"announcedDate":"2026-03-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"信息服务","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-26"},{"market":"US","date":"2026-03-05","symbol":"III","fiscalQuarterEnding":"2025/12","expectedEps":0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":0.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"III\",market:\"US\",,,undefined,":[{"executeDate":"2021-06-03","recordDate":"2021-06-04","paymentDate":"2021-06-18","value":0.03,"currency":"USD"},{"executeDate":"2021-09-03","recordDate":"2021-09-07","paymentDate":"2021-09-24","value":0.03,"currency":"USD"},{"executeDate":"2021-12-02","recordDate":"2021-12-03","paymentDate":"2021-12-17","value":0.03,"currency":"USD"},{"executeDate":"2022-03-18","recordDate":"2022-03-21","paymentDate":"2022-04-06","value":0.03,"currency":"USD"},{"executeDate":"2022-06-02","recordDate":"2022-06-03","paymentDate":"2022-06-17","value":0.04,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"III\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1679457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/III\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"III","date":"2026-07-29","current":19.574132,"percent":0.521987,"low":-221.876594,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"high":68.328883,"avg":1.104082,"sd":58.997004,"marketCap":198532987},"quantilePoints":[{"date":"2021-07-30","current":38.021758,"twenty":29.112158,"median":36.556933,"eighty":53.929654,"marketCap":286646033},{"date":"2021-08-06","current":37.830694,"twenty":29.227833,"median":36.811685,"eighty":53.929654,"marketCap":285205601},{"date":"2021-08-13","current":30.04792,"twenty":29.342728,"median":36.811685,"eighty":53.929654,"marketCap":331488657},{"date":"2021-08-20","current":29.125396,"twenty":29.392136,"median":36.811685,"eighty":53.929654,"marketCap":321311374},{"date":"2021-08-27","current":31.014374,"twenty":29.446637,"median":36.811685,"eighty":53.929654,"marketCap":342150573},{"date":"2021-09-03","current":32.376195,"twenty":29.490206,"median":36.811685,"eighty":53.929654,"marketCap":357174181},{"date":"2021-09-10","current":33.869805,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":373651688},{"date":"2021-09-17","current":33.210859,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":366382200},{"date":"2021-09-24","current":32.859422,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":362505139},{"date":"2021-10-01","current":31.936898,"twenty":29.540957,"median":36.811685,"eighty":53.929654,"marketCap":352327856},{"date":"2021-10-08","current":33.386578,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-15","current":31.849038,"twenty":29.673426,"median":36.811685,"eighty":53.929654,"marketCap":351358591},{"date":"2021-10-22","current":33.386578,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":368320730},{"date":"2021-10-29","current":35.802712,"twenty":29.76934,"median":36.811685,"eighty":53.929654,"marketCap":394975520},{"date":"2021-11-05","current":32.443868,"twenty":29.838435,"median":36.811685,"eighty":53.929654,"marketCap":434715388},{"date":"2021-11-12","current":34.955794,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":468372678},{"date":"2021-11-19","current":34.77297,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":465923030},{"date":"2021-11-26","current":30.348649,"twenty":29.845286,"median":36.811685,"eighty":53.929654,"marketCap":406641551},{"date":"2021-12-03","current":28.886064,"twenty":29.82833,"median":36.811685,"eighty":53.929654,"marketCap":387044368},{"date":"2021-12-10","current":29.507663,"twenty":29.768974,"median":36.811685,"eighty":53.929654,"marketCap":395373171},{"date":"2021-12-17","current":26.984703,"twenty":29.661234,"median":36.811685,"eighty":53.929654,"marketCap":361568030},{"date":"2021-12-23","current":28.081642,"twenty":29.603046,"median":36.811685,"eighty":53.929654,"marketCap":376265917},{"date":"2021-12-31","current":27.862254,"twenty":29.504246,"median":36.811685,"eighty":53.929654,"marketCap":373326339},{"date":"2022-01-07","current":26.399668,"twenty":29.437039,"median":36.760945,"eighty":53.927618,"marketCap":353729156},{"date":"2022-01-14","current":25.302729,"twenty":29.255815,"median":36.760945,"eighty":53.927618,"marketCap":339031269},{"date":"2022-01-21","current":23.145416,"twenty":29.125104,"median":36.760945,"eighty":53.927618,"marketCap":310125424},{"date":"2022-01-28","current":22.670075,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":303756339},{"date":"2022-02-04","current":24.863954,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":333152114},{"date":"2022-02-11","current":25.887763,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":346870142},{"date":"2022-02-18","current":27.130961,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":363527748},{"date":"2022-02-25","current":26.107151,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":349809720},{"date":"2022-03-04","current":27.423478,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":367447185},{"date":"2022-03-11","current":22.999463,"twenty":29.042114,"median":36.760945,"eighty":53.927618,"marketCap":357158663},{"date":"2022-03-18","current":22.63323,"twenty":28.930434,"median":36.760945,"eighty":53.927618,"marketCap":351471428},{"date":"2022-03-25","current":21.138876,"twenty":28.720555,"median":36.760945,"eighty":53.927618,"marketCap":328265612},{"date":"2022-04-01","current":21.387935,"twenty":28.563876,"median":36.760945,"eighty":53.927618,"marketCap":332133248},{"date":"2022-04-08","current":20.640759,"twenty":28.47654,"median":36.760945,"eighty":53.927618,"marketCap":320530340},{"date":"2022-04-14","current":20.79642,"twenty":28.362763,"median":36.760945,"eighty":53.927618,"marketCap":322947612},{"date":"2022-04-22","current":19.769052,"twenty":28.214177,"median":36.760945,"eighty":53.927618,"marketCap":306993613},{"date":"2022-04-29","current":19.519993,"twenty":28.004454,"median":36.760945,"eighty":53.927618,"marketCap":303125977},{"date":"2022-05-06","current":18.430361,"twenty":27.931066,"median":36.760945,"eighty":53.927618,"marketCap":286205069},{"date":"2022-05-13","current":17.907825,"twenty":27.846885,"median":36.556933,"eighty":53.927618,"marketCap":305059795},{"date":"2022-05-20","current":17.625134,"twenty":27.555111,"median":36.381032,"eighty":53.927618,"marketCap":300244158},{"date":"2022-05-27","current":18.472496,"twenty":27.379781,"median":36.238493,"eighty":53.927618,"marketCap":314678973},{"date":"2022-06-03","current":18.274778,"twenty":27.167526,"median":36.092994,"eighty":53.927618,"marketCap":311310849},{"date":"2022-06-10","current":16.269354,"twenty":26.614253,"median":35.829538,"eighty":53.927618,"marketCap":277148453},{"date":"2022-06-17","current":16.551809,"twenty":26.372596,"median":35.640231,"eighty":53.822908,"marketCap":281960058},{"date":"2022-06-24","current":17.879343,"twenty":26.107151,"median":35.537925,"eighty":53.79462,"marketCap":304574602},{"date":"2022-07-01","current":19.093895,"twenty":25.975518,"median":35.458953,"eighty":53.271145,"marketCap":325264504},{"date":"2022-07-08","current":19.856521,"twenty":25.412423,"median":35.283172,"eighty":53.041064,"marketCap":338255838},{"date":"2022-07-15","current":19.291613,"twenty":24.849328,"median":35.178625,"eighty":52.906055,"marketCap":328632628},{"date":"2022-07-22","current":20.138975,"twenty":24.08147,"median":35.060591,"eighty":52.665026,"marketCap":343067443},{"date":"2022-07-29","current":21.071074,"twenty":23.209281,"median":34.955794,"eighty":52.523833,"marketCap":358945740},{"date":"2022-08-05","current":21.635982,"twenty":22.947966,"median":34.77297,"eighty":52.322009,"marketCap":368568950},{"date":"2022-08-12","current":16.409925,"twenty":22.628286,"median":34.72983,"eighty":52.322009,"marketCap":293507911},{"date":"2022-08-19","current":16.552576,"twenty":22.371718,"median":34.475053,"eighty":52.322009,"marketCap":296059374},{"date":"2022-08-26","current":16.15211,"twenty":21.544722,"median":34.282985,"eighty":52.322009,"marketCap":288896647},{"date":"2022-09-02","current":14.950714,"twenty":21.183009,"median":34.23369,"eighty":52.322009,"marketCap":267408467},{"date":"2022-09-09","current":14.817225,"twenty":21.074397,"median":34.193624,"eighty":52.322009,"marketCap":265020891},{"date":"2022-09-16","current":14.123085,"twenty":20.842582,"median":34.06831,"eighty":52.322009,"marketCap":252605498},{"date":"2022-09-23","current":12.948386,"twenty":20.628306,"median":33.98562,"eighty":52.322009,"marketCap":231594833},{"date":"2022-09-30","current":12.708107,"twenty":20.189817,"median":33.90293,"eighty":52.322009,"marketCap":227297197},{"date":"2022-10-07","current":12.761502,"twenty":19.975152,"median":33.869805,"eighty":52.322009,"marketCap":228252227},{"date":"2022-10-14","current":12.814898,"twenty":19.650749,"median":33.737549,"eighty":52.322009,"marketCap":229207257},{"date":"2022-10-21","current":13.268758,"twenty":19.370558,"median":33.630766,"eighty":52.322009,"marketCap":237325014},{"date":"2022-10-28","current":14.790528,"twenty":19.172983,"median":33.57217,"eighty":52.322009,"marketCap":264543376},{"date":"2022-11-04","current":11.924698,"twenty":18.940931,"median":33.57217,"eighty":52.322009,"marketCap":226819682},{"date":"2022-11-11","current":14.156908,"twenty":18.67839,"median":33.490051,"eighty":52.100253,"marketCap":269278547},{"date":"2022-11-18","current":14.055967,"twenty":18.383013,"median":33.406789,"eighty":51.591958,"marketCap":267358557},{"date":"2022-11-25","current":13.52603,"twenty":17.941577,"median":33.349337,"eighty":51.184669,"marketCap":257278611},{"date":"2022-12-02","current":13.223208,"twenty":17.811433,"median":33.272057,"eighty":50.857754,"marketCap":251518642},{"date":"2022-12-09","current":12.59233,"twenty":17.329516,"median":33.261363,"eighty":50.482919,"marketCap":239518707},{"date":"2022-12-16","current":11.406279,"twenty":16.879455,"median":33.138265,"eighty":50.207132,"marketCap":216958829},{"date":"2022-12-23","current":11.507219,"twenty":16.612253,"median":33.07907,"eighty":49.781169,"marketCap":218878818},{"date":"2022-12-30","current":11.60816,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":220798808},{"date":"2023-01-06","current":12.264273,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":233278741},{"date":"2023-01-13","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-01-20","current":12.970857,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246718668},{"date":"2023-01-27","current":13.122268,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":249598653},{"date":"2023-02-03","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-10","current":13.879322,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":263998575},{"date":"2023-02-17","current":13.677441,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":260158596},{"date":"2023-02-24","current":12.945622,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":246238671},{"date":"2023-03-03","current":13.500795,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":256798614},{"date":"2023-03-10","current":12.166618,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239998705},{"date":"2023-03-17","current":11.411218,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":225097683},{"date":"2023-03-24","current":12.147425,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":239620114},{"date":"2023-03-31","current":12.490989,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":246397249},{"date":"2023-04-06","current":12.294667,"twenty":16.382886,"median":33.063229,"eighty":49.624683,"marketCap":242524601},{"date":"2023-04-14","current":12.687311,"twenty":16.399164,"median":33.067908,"eighty":49.624683,"marketCap":250269897},{"date":"2023-04-21","current":12.270127,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":242040520},{"date":"2023-04-28","current":12.196506,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":240588276},{"date":"2023-05-05","current":12.245586,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":241556438},{"date":"2023-05-12","current":13.473902,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":246397249},{"date":"2023-05-19","current":14.20765,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":259815303},{"date":"2023-05-26","current":13.413927,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":245300481},{"date":"2023-06-02","current":13.387469,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":244816654},{"date":"2023-06-09","current":13.943076,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":254977029},{"date":"2023-06-16","current":14.075363,"twenty":16.45538,"median":33.071968,"eighty":49.624683,"marketCap":257396166},{"date":"2023-06-23","current":15.080746,"twenty":16.529212,"median":33.076029,"eighty":49.624683,"marketCap":275781606},{"date":"2023-06-30","current":14.154735,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":258847648},{"date":"2023-07-07","current":13.810789,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":252557892},{"date":"2023-07-14","current":14.260565,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":260782957},{"date":"2023-07-21","current":14.048906,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":256912338},{"date":"2023-07-28","current":13.387469,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":244816654},{"date":"2023-08-04","current":16.278939,"twenty":16.551809,"median":33.076029,"eighty":49.624683,"marketCap":254977029},{"date":"2023-08-11","current":16.275803,"twenty":16.382336,"median":32.997393,"eighty":49.558778,"marketCap":254927904},{"date":"2023-08-18","current":15.376759,"twenty":16.278939,"median":32.930248,"eighty":49.391703,"marketCap":240846172},{"date":"2023-08-25","current":15.40776,"twenty":16.232204,"median":32.835614,"eighty":49.042233,"marketCap":241331749},{"date":"2023-09-01","current":16.120795,"twenty":16.15211,"median":32.803437,"eighty":48.925743,"marketCap":252500019},{"date":"2023-09-08","current":15.035742,"twenty":16.031821,"median":32.75433,"eighty":48.809254,"marketCap":235504825},{"date":"2023-09-15","current":14.446713,"twenty":15.779779,"median":32.64723,"eighty":48.576274,"marketCap":226278863},{"date":"2023-09-22","current":13.733678,"twenty":15.562768,"median":32.609831,"eighty":48.459784,"marketCap":215110593},{"date":"2023-09-29","current":13.423662,"twenty":15.404575,"median":32.491023,"eighty":48.459784,"marketCap":210254823},{"date":"2023-10-06","current":13.950688,"twenty":15.345757,"median":32.431996,"eighty":48.459784,"marketCap":218509632},{"date":"2023-10-13","current":13.361659,"twenty":15.080746,"median":32.334816,"eighty":48.343294,"marketCap":209283669},{"date":"2023-10-20","current":13.051644,"twenty":14.911736,"median":32.178609,"eighty":48.324535,"marketCap":204427900},{"date":"2023-10-27","current":12.77263,"twenty":14.827387,"median":32.156546,"eighty":48.226804,"marketCap":200057707},{"date":"2023-11-03","current":15.032891,"twenty":14.614323,"median":32.100506,"eighty":48.180208,"marketCap":200057707},{"date":"2023-11-10","current":15.314305,"twenty":14.614323,"median":32.044484,"eighty":48.063719,"marketCap":203802770},{"date":"2023-11-17","current":15.975354,"twenty":14.614323,"median":32.022403,"eighty":47.932458,"marketCap":212600012},{"date":"2023-11-24","current":16.048804,"twenty":14.614323,"median":31.943078,"eighty":47.714249,"marketCap":213577483},{"date":"2023-12-01","current":15.27758,"twenty":14.614323,"median":31.841671,"eighty":47.187487,"marketCap":203314034},{"date":"2023-12-08","current":16.673128,"twenty":14.619662,"median":31.750721,"eighty":46.490677,"marketCap":221885989},{"date":"2023-12-15","current":16.673128,"twenty":14.619662,"median":31.53949,"eighty":46.22662,"marketCap":221885989},{"date":"2023-12-22","current":17.407627,"twenty":14.619662,"median":31.467912,"eighty":45.230776,"marketCap":231660702},{"date":"2023-12-29","current":17.554527,"twenty":14.614323,"median":31.234022,"eighty":45.040598,"marketCap":233615645},{"date":"2024-01-05","current":16.673128,"twenty":14.608983,"median":31.080268,"eighty":44.740412,"marketCap":221885989},{"date":"2024-01-12","current":16.452778,"twenty":14.608983,"median":30.97496,"eighty":44.593596,"marketCap":218953575},{"date":"2024-01-19","current":16.269154,"twenty":14.603644,"median":30.818124,"eighty":44.593596,"marketCap":216509897},{"date":"2024-01-26","current":17.554527,"twenty":14.608983,"median":30.62605,"eighty":44.463847,"marketCap":233615645},{"date":"2024-02-02","current":16.820028,"twenty":14.608983,"median":30.523385,"eighty":44.220503,"marketCap":223840932},{"date":"2024-02-09","current":16.122254,"twenty":14.608983,"median":30.418362,"eighty":43.923358,"marketCap":214554954},{"date":"2024-02-16","current":16.305879,"twenty":14.608983,"median":30.260593,"eighty":43.769861,"marketCap":216998633},{"date":"2024-02-23","current":15.608105,"twenty":14.608983,"median":30.141793,"eighty":42.75327,"marketCap":207712655},{"date":"2024-03-01","current":15.901904,"twenty":14.614323,"median":30.092043,"eighty":42.030433,"marketCap":211622540},{"date":"2024-03-08","current":34.784891,"twenty":14.614323,"median":29.930691,"eighty":41.395649,"marketCap":214066219},{"date":"2024-03-15","current":30.710223,"twenty":14.614323,"median":29.930691,"eighty":41.308941,"marketCap":188990710},{"date":"2024-03-22","current":32.281078,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":198657754},{"date":"2024-03-28","current":31.652736,"twenty":14.614323,"median":30.092043,"eighty":41.308941,"marketCap":194790936},{"date":"2024-04-05","current":31.966907,"twenty":14.608983,"median":30.092453,"eighty":41.339259,"marketCap":196724345},{"date":"2024-04-12","current":30.238966,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":186090597},{"date":"2024-04-19","current":28.589568,"twenty":14.608983,"median":30.167144,"eighty":41.339259,"marketCap":175940200},{"date":"2024-04-26","current":27.411426,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":168689917},{"date":"2024-05-03","current":26.39037,"twenty":14.614323,"median":30.165826,"eighty":41.308941,"marketCap":162406339},{"date":"2024-05-10","current":25.919114,"twenty":14.614323,"median":30.117759,"eighty":41.308941,"marketCap":159506226},{"date":"2024-05-17","current":-211.151442,"twenty":14.503289,"median":29.916131,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-24","current":-211.151442,"twenty":14.319403,"median":29.768426,"eighty":41.308941,"marketCap":153295947},{"date":"2024-05-31","current":-216.514018,"twenty":14.260565,"median":29.603046,"eighty":41.308941,"marketCap":157189177},{"date":"2024-06-07","current":-209.810798,"twenty":14.204967,"median":29.476834,"eighty":41.308941,"marketCap":152322639},{"date":"2024-06-14","current":-212.492085,"twenty":14.156908,"median":29.278446,"eighty":41.339259,"marketCap":154269254},{"date":"2024-06-21","current":-203.777899,"twenty":14.123085,"median":28.941526,"eighty":41.369578,"marketCap":147942755},{"date":"2024-06-28","current":-205.788865,"twenty":14.101821,"median":28.815898,"eighty":41.369578,"marketCap":149402716},{"date":"2024-07-05","current":-205.118543,"twenty":14.061456,"median":28.592041,"eighty":41.369578,"marketCap":148916062},{"date":"2024-07-12","current":-210.48112,"twenty":13.995991,"median":28.46557,"eighty":41.369578,"marketCap":152809293},{"date":"2024-07-15","current":-211.151442,"twenty":13.995991,"median":28.446337,"eighty":41.369578,"marketCap":153295947},{"date":"2024-08-02","current":-221.876594,"twenty":13.965764,"median":28.594514,"eighty":41.395649,"marketCap":161082407},{"date":"2024-08-09","current":-155.153276,"twenty":13.890161,"median":28.447288,"eighty":41.369578,"marketCap":158411495},{"date":"2024-08-16","current":-157.547617,"twenty":13.879322,"median":28.196854,"eighty":41.040322,"marketCap":160856117},{"date":"2024-08-23","current":-158.026486,"twenty":13.823503,"median":28.008512,"eighty":39.690077,"marketCap":161345042},{"date":"2024-08-30","current":-166.167244,"twenty":13.795681,"median":27.935383,"eighty":38.544,"marketCap":169656756},{"date":"2024-09-06","current":-154.195541,"twenty":13.753035,"median":27.569737,"eighty":38.347232,"marketCap":157433647},{"date":"2024-09-13","current":-151.322331,"twenty":13.704502,"median":27.313784,"eighty":38.122137,"marketCap":154500100},{"date":"2024-09-20","current":-156.111013,"twenty":13.672394,"median":27.130961,"eighty":37.980944,"marketCap":159389344},{"date":"2024-09-27","current":-154.195541,"twenty":13.62697,"median":26.595041,"eighty":37.894382,"marketCap":157433647},{"date":"2024-10-04","current":-155.153276,"twenty":13.599214,"median":26.468913,"eighty":37.779744,"marketCap":158411495},{"date":"2024-10-11","current":-150.364595,"twenty":13.553316,"median":26.233285,"eighty":37.589923,"marketCap":153522252},{"date":"2024-10-18","current":-152.280068,"twenty":13.524775,"median":26.107151,"eighty":37.433759,"marketCap":155477949},{"date":"2024-10-25","current":-147.012518,"twenty":13.48942,"median":25.919114,"eighty":37.27024,"marketCap":150099781},{"date":"2024-10-31","current":-150.364595,"twenty":13.450324,"median":25.485552,"eighty":37.015362,"marketCap":153522252},{"date":"2024-11-08","current":-52.964156,"twenty":13.423662,"median":24.845672,"eighty":36.750798,"marketCap":162811815},{"date":"2024-11-15","current":-53.318651,"twenty":13.387469,"median":24.004684,"eighty":36.556933,"marketCap":163901532},{"date":"2024-11-22","current":-53.238832,"twenty":13.341574,"median":23.198637,"eighty":36.327656,"marketCap":163656170},{"date":"2024-11-29","current":-58.905934,"twenty":13.314055,"median":22.981027,"eighty":36.238493,"marketCap":181076842},{"date":"2024-12-06","current":-58.267387,"twenty":13.27171,"median":22.651653,"eighty":35.999189,"marketCap":179113949},{"date":"2024-12-13","current":-58.427024,"twenty":13.239501,"median":22.455197,"eighty":35.783905,"marketCap":179604672},{"date":"2024-12-20","current":-55.074654,"twenty":13.19425,"median":21.621859,"eighty":35.607032,"marketCap":169299486},{"date":"2024-12-27","current":-53.957197,"twenty":13.130069,"median":21.342486,"eighty":35.505726,"marketCap":165864424},{"date":"2025-01-03","current":-51.88192,"twenty":13.070245,"median":21.138876,"eighty":35.459393,"marketCap":159485023},{"date":"2025-01-10","current":-49.96628,"twenty":13.021327,"median":20.901601,"eighty":35.211692,"marketCap":153596345},{"date":"2025-01-17","current":-51.88192,"twenty":12.972548,"median":20.664813,"eighty":35.117714,"marketCap":159485023},{"date":"2025-01-24","current":-51.562647,"twenty":12.952487,"median":20.578494,"eighty":35.032487,"marketCap":158503577},{"date":"2025-01-31","current":-49.168097,"twenty":12.915203,"median":20.138975,"eighty":34.93156,"marketCap":151142730},{"date":"2025-02-07","current":-51.083737,"twenty":12.802486,"median":19.831317,"eighty":34.780123,"marketCap":157031408},{"date":"2025-02-14","current":-51.40301,"twenty":12.725025,"median":19.519993,"eighty":34.72983,"marketCap":158012854},{"date":"2025-02-21","current":-49.48737,"twenty":12.667751,"median":19.333199,"eighty":34.575342,"marketCap":152124176},{"date":"2025-02-28","current":-49.00846,"twenty":12.601316,"median":19.122141,"eighty":34.324158,"marketCap":150652007},{"date":"2025-03-07","current":53.583718,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":152124176},{"date":"2025-03-14","current":56.52218,"twenty":12.589786,"median":18.928478,"eighty":34.23369,"marketCap":160466470},{"date":"2025-03-21","current":63.229713,"twenty":12.589786,"median":18.928478,"eighty":34.39907,"marketCap":179509154},{"date":"2025-03-28","current":64.079574,"twenty":12.589786,"median":18.928478,"eighty":34.546571,"marketCap":181921911},{"date":"2025-04-04","current":63.569657,"twenty":12.589786,"median":18.928478,"eighty":34.686729,"marketCap":180474257},{"date":"2025-04-11","current":60.17021,"twenty":12.590422,"median":18.990743,"eighty":34.733776,"marketCap":170823227},{"date":"2025-04-17","current":62.889768,"twenty":12.590422,"median":18.990743,"eighty":34.814432,"marketCap":178544051},{"date":"2025-04-25","current":62.379851,"twenty":12.589786,"median":18.928478,"eighty":34.943677,"marketCap":177096396},{"date":"2025-05-02","current":64.589491,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":183369566},{"date":"2025-05-09","current":25.015629,"twenty":12.589786,"median":18.928478,"eighty":35.046539,"marketCap":193020596},{"date":"2025-05-16","current":29.987043,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":231380025},{"date":"2025-05-23","current":29.29984,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":226077566},{"date":"2025-05-30","current":29.237367,"twenty":12.589786,"median":18.928478,"eighty":34.985212,"marketCap":225595524},{"date":"2025-06-06","current":29.424786,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":227041650},{"date":"2025-06-13","current":29.862097,"twenty":12.589786,"median":18.928478,"eighty":34.964732,"marketCap":230415942},{"date":"2025-06-20","current":29.612205,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":228487775},{"date":"2025-06-27","current":28.862529,"twenty":12.58915,"median":18.866214,"eighty":34.964732,"marketCap":222703274},{"date":"2025-07-03","current":31.923706,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":246323318},{"date":"2025-07-11","current":31.486395,"twenty":12.58915,"median":18.866214,"eighty":34.955794,"marketCap":242949026},{"date":"2025-07-18","current":29.237367,"twenty":12.58915,"median":18.866214,"eighty":34.89521,"marketCap":225595524},{"date":"2025-07-25","current":28.425218,"twenty":12.58915,"median":18.866214,"eighty":34.834126,"marketCap":219328982},{"date":"2025-08-01","current":26.925866,"twenty":12.58915,"median":18.866214,"eighty":34.784891,"marketCap":207759981},{"date":"2025-08-08","current":25.754678,"twenty":12.58915,"median":18.866214,"eighty":34.77297,"marketCap":202457522},{"date":"2025-08-15","current":30.470866,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":239531480},{"date":"2025-08-22","current":29.489913,"twenty":12.58915,"median":18.866214,"eighty":34.221243,"marketCap":231820205},{"date":"2025-08-29","current":31.39051,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":246760801},{"date":"2025-09-05","current":32.432773,"twenty":12.58915,"median":18.85295,"eighty":34.118522,"marketCap":254954031},{"date":"2025-09-12","current":32.126225,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":252544257},{"date":"2025-09-19","current":33.965513,"twenty":12.58915,"median":18.866214,"eighty":34.114807,"marketCap":267002898},{"date":"2025-09-26","current":35.314324,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":277605901},{"date":"2025-10-03","current":34.639918,"twenty":12.58915,"median":18.866214,"eighty":34.639918,"marketCap":272304399},{"date":"2025-10-10","current":33.842894,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":266038988},{"date":"2025-10-17","current":33.413727,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":262665306},{"date":"2025-10-24","current":34.088132,"twenty":12.58915,"median":18.866214,"eighty":34.704469,"marketCap":267966807},{"date":"2025-10-31","current":33.536346,"twenty":12.58915,"median":18.866214,"eighty":34.748399,"marketCap":263629215},{"date":"2025-11-07","current":28.380485,"twenty":12.58915,"median":18.866214,"eighty":34.701228,"marketCap":277248962},{"date":"2025-11-14","current":25.733601,"twenty":12.58915,"median":18.866214,"eighty":34.517299,"marketCap":251391546},{"date":"2025-11-21","current":24.557208,"twenty":12.58915,"median":18.866214,"eighty":34.309102,"marketCap":239899361},{"date":"2025-11-28","current":26.370814,"twenty":12.58915,"median":18.866214,"eighty":34.210751,"marketCap":257616479},{"date":"2025-12-05","current":28.282453,"twenty":12.58915,"median":18.866214,"eighty":33.965513,"marketCap":276291280},{"date":"2025-12-12","current":29.409829,"twenty":12.58915,"median":18.866214,"eighty":33.842894,"marketCap":287304624},{"date":"2025-12-19","current":29.26278,"twenty":12.58915,"median":18.866214,"eighty":33.529773,"marketCap":285868100},{"date":"2025-12-26","current":29.066715,"twenty":12.58915,"median":18.866214,"eighty":33.430508,"marketCap":283952736},{"date":"2026-01-02","current":28.331469,"twenty":12.58915,"median":18.866214,"eighty":33.342648,"marketCap":276770121},{"date":"2026-01-09","current":29.164747,"twenty":12.58915,"median":18.866214,"eighty":33.210859,"marketCap":284910418},{"date":"2026-01-16","current":29.80196,"twenty":12.58915,"median":18.866214,"eighty":33.054432,"marketCap":291135352},{"date":"2026-01-23","current":27.792289,"twenty":12.58915,"median":18.866214,"eighty":32.903351,"marketCap":271502869},{"date":"2026-01-30","current":27.400158,"twenty":12.58915,"median":18.866214,"eighty":32.739321,"marketCap":267672141},{"date":"2026-02-06","current":24.998355,"twenty":12.58915,"median":18.866214,"eighty":32.548436,"marketCap":244208930},{"date":"2026-02-13","current":22.35147,"twenty":12.58915,"median":18.866214,"eighty":32.359621,"marketCap":218351514},{"date":"2026-02-20","current":22.841634,"twenty":12.58915,"median":18.866214,"eighty":32.126225,"marketCap":223139924},{"date":"2026-02-27","current":23.429831,"twenty":12.58915,"median":18.866214,"eighty":32.068687,"marketCap":228886017},{"date":"2026-03-06","current":24.400849,"twenty":12.58915,"median":18.866214,"eighty":31.936898,"marketCap":227928335},{"date":"2026-03-13","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.809821,"marketCap":191174107},{"date":"2026-03-20","current":19.649525,"twenty":12.58915,"median":18.866214,"eighty":31.731279,"marketCap":183546212},{"date":"2026-03-27","current":19.7516,"twenty":12.58915,"median":18.866214,"eighty":31.635749,"marketCap":184499699},{"date":"2026-04-02","current":19.598487,"twenty":12.58915,"median":18.866214,"eighty":31.486395,"marketCap":183069469},{"date":"2026-04-10","current":20.415091,"twenty":12.58915,"median":18.866214,"eighty":31.417108,"marketCap":190697364},{"date":"2026-04-17","current":21.282732,"twenty":12.58915,"median":18.866214,"eighty":31.338565,"marketCap":198802001},{"date":"2026-04-24","current":20.466129,"twenty":12.58915,"median":18.866214,"eighty":31.102233,"marketCap":191174107},{"date":"2026-05-01","current":20.823393,"twenty":12.58915,"median":18.866214,"eighty":30.970444,"marketCap":194511311},{"date":"2026-05-08","current":18.809916,"twenty":12.58915,"median":18.839687,"eighty":30.838724,"marketCap":198802001},{"date":"2026-05-15","current":19.2371,"twenty":12.58915,"median":18.809916,"eighty":30.611773,"marketCap":203316914},{"date":"2026-05-22","current":19.780266,"twenty":12.58915,"median":18.739199,"eighty":30.409557,"marketCap":209057627},{"date":"2026-05-29","current":20.504486,"twenty":12.58915,"median":18.718829,"eighty":30.267569,"marketCap":216711911},{"date":"2026-06-05","current":19.644474,"twenty":12.58915,"median":18.739199,"eighty":30.174462,"marketCap":207622449},{"date":"2026-06-12","current":19.372892,"twenty":12.58915,"median":18.739199,"eighty":30.111989,"marketCap":204752092},{"date":"2026-06-18","current":18.829726,"twenty":12.58915,"median":18.698459,"eighty":29.987245,"marketCap":199011379},{"date":"2026-06-26","current":18.377089,"twenty":12.58915,"median":18.492688,"eighty":29.953208,"marketCap":194227452},{"date":"2026-07-02","current":18.965518,"twenty":12.58915,"median":18.492688,"eighty":29.862097,"marketCap":200446558},{"date":"2026-07-10","current":18.422353,"twenty":12.58915,"median":18.42051,"eighty":29.749013,"marketCap":194705845},{"date":"2026-07-17","current":18.558144,"twenty":12.58915,"median":18.377089,"eighty":29.67784,"marketCap":196141023},{"date":"2026-07-24","current":17.381286,"twenty":12.58915,"median":18.28067,"eighty":29.612205,"marketCap":183702812},{"date":"2026-07-29","current":18.784463,"twenty":12.58915,"median":18.223516,"eighty":29.572197,"marketCap":198532987}],"updateTime":1785441174196},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"III\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655836775","title":"信息服务业增势良好 广东两业协同发展更有支撑","url":"https://stock-news.laohu8.com/highlight/detail?id=2655836775","media":"金羊网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655836775?lang=zh_cn&edition=fundamental","pubTime":"2026-07-29 07:02","pubTimestamp":1785279720,"startTime":"0","endTime":"0","summary":"信息服务业保持较快增长，进一步增强了广东经济平稳运行的支撑力量。面向下一步，广东仍需加强基础软件、工业软件等关键领域研发，培育更具竞争力的信息服务企业，将数智技术转化为解决实际生产问题的专业能力，为广东推动制造业与服务业协同发展增添力量，为经济稳中提质注入更多活力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-07-29/doc-inikmivv5984205.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-07-29/doc-inikmivv5984205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100808","title":"翰森制药(03692)：HS-20093治疗骨肉瘤III期临床研究达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100808","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100808?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 18:01","pubTimestamp":1785232902,"startTime":"0","endTime":"0","summary":"智通财经APP讯，翰森制药 公布，该集团自研B7-H3靶向抗体-药物偶联物HS-20093，在用于既往接受过至少二线系统治疗后进展或复发的骨肉瘤患者的关键性III期临床试验中达到主要终点。安全性特征与既往研究结果一致，未发现新的安全性信号。ARTEMIS-011研究详细数据预计未来在国际肿瘤学术大会上予以公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK1583","III","BK1191","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071182","title":"港股异动 | 乐普生物(02157)涨近4% CMG901全球III期临床试验CLARITY-GASTRIC01取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071182","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071182?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 15:28","pubTimestamp":1785223688,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，乐普生物涨近4%，早盘曾涨逾12%。截至发稿，涨3.83%，报4.61港元，成交额9164.84万港元。消息面上，7月28日，乐普生物发布公告，有关集团与AstraZeneca AB就抗体偶联药物候选药物CMG901合作的最新情况。截至本公告日期，CLARITY-Gastric01全球III期临床试验公布的积极顶线结果显示，与研究者选择的治疗方案相比，sonesitatug vedotin在二线及后线(2L+) Claudin 18.2阳性晚期胃癌患者中展现出具有统计学显著性且极具临床意义的总生存期改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02157","IBBJ","MDTX","KCAI","BK4134","IBBQ","VXUS","PSYK","BK4585","III","BK1161","BMED","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654127078","title":"乐普生物：CMG901全球III期临床试验CLARITY-GASTRIC01达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2654127078","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654127078?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 12:32","pubTimestamp":1785213120,"startTime":"0","endTime":"0","summary":"【乐普生物：CMG901全球III期临床试验CLARITY-GASTRIC01达主要终点】乐普生物（02157.HK）发布自愿公告，公告基本信息：公司于2026年7月28日发布自愿性公告，披露其与阿斯利康合作开发的抗体偶联药物CMG901（sonesitatugvedotin，AZD0901）全球III期临床试验CLARITY-GASTRIC01取得积极顶线结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607283823312261.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607283823312261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4134","IBBQ","MDTX","BMED","III","BK1161","PSYK","02157","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654020773","title":"康诺亚-B：CMG901全球III期临床获积极顶线结果，OS改善具统计学显著性","url":"https://stock-news.laohu8.com/highlight/detail?id=2654020773","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654020773?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 12:01","pubTimestamp":1785211290,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["III","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654043933","title":"石药集团：盐酸阿姆西汀肠溶片III期临床试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2654043933","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654043933?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 21:15","pubTimestamp":1785158100,"startTime":"0","endTime":"0","summary":"石药集团：盐酸阿姆西汀肠溶片III期临床试验达主要终点","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607273822364345.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607273822364345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01093","LU1008478684.HKD","LU1152091168.USD","BMED","IE00BZ08YR35.GBP","LU0072913022.USD","LU1960683339.HKD","III","IE0008369823.USD","LU0880133367.SGD","BK1521","LU1813983027.USD","LU1152091754.HKD","LU0501845795.SGD","IE00BZ08YT58.USD","LU1226287875.USD","IE00B031HY20.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1226288170.HKD","LU0314109678.HKD","LU1226287792.SGD","BK1515","LU1807302812.USD","PSYK","IBBJ","IE00BZ08YS42.EUR","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","BK4134","BK1191","LU0315179316.USD","LU0067412154.USD","LU1993786604.SGD","SG9999004220.SGD","MDTX","LU2039709279.SGD","KURE","LU1226288253.USD","LU1951186391.HKD","LU0140636845.USD","LU1328277881.USD","IE00B5MMRT66.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654385043","title":"Arrowhead完成Zodasiran全球III期YOSEMITE试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2654385043","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654385043?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 21:14","pubTimestamp":1785158040,"startTime":"0","endTime":"0","summary":"Arrowhead Pharmaceuticals今日宣布，其针对Zodasiran的全球III期YOSEMITE临床试验已完成患者入组。YOSEMITE试验最初计划招募60名受试者，但基于全球范围内HoFH患者与医生的强烈响应，最终入组人数增至70人。此前的II期GATEWAY研究显示，Zodasiran在HoFH患者中带来了具有临床意义的LDL-C水平降低，且安全性良好，未出现药物相关严重不良事件或死亡。Arrowhead预计该研究将于2027年中期完成，若结果积极，计划随后在多个地区提交监管审批申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-27/doc-inikhcmc0729606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654048711","title":"阿斯利康Sone-Ve在晚期胃癌III期试验中显著延长总生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2654048711","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654048711?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 21:06","pubTimestamp":1785157560,"startTime":"0","endTime":"0","summary":"阿斯利康今日公布，其潜在同类首创CLDN18.2靶向抗体偶联药物Sone-Ve在III期CLARITY-Gastric01试验中达到主要终点，与研究者选择的治疗方案相比，在二线及后线CLDN18.2阳性晚期胃癌患者中实现了具有统计学显著性和高度临床意义的总生存期改善。晚期胃癌患者预后极差，一线治疗进展后中位生存期仅5-9个月。阿斯利康肿瘤研发执行副总裁Susan Galbraith表示，Sone-Ve有望通过新型靶向ADC替代传统化疗，重塑胃癌治疗格局。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-27/doc-inikhckx3037081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2089984988.USD","LU0708994859.HKD","LU2237443382.USD","AZNH","LU0310800379.SGD","LU0058720904.USD","IE00B3T34201.USD","LU2462157665.USD","LU0109394709.USD","LU2456880835.USD","III","LU2236285917.USD","BK4134","LU2237443465.HKD","LU0320765992.SGD","LU2237443978.SGD","LU0889565916.HKD","BK4588","AZN","BK4568","LU0029864427.USD","LU0289739699.SGD","LU0432979614.USD","LU1829250122.USD","BK4585","LU0128525929.USD","BK4007","LU2417539215.USD","LU2237443895.HKD","LU2237443622.USD","LU2468319806.SGD","LU1267930573.SGD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654683048","title":"石药集团：盐酸阿姆西汀肠溶片III期临床试验达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2654683048","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654683048?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 20:59","pubTimestamp":1785157151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BMED","MDTX","IBBJ","III","PSYK","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654169740","title":"诺诚健华：ICP-488治疗银屑病III期试验达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2654169740","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654169740?lang=zh_cn&edition=fundamental","pubTime":"2026-07-27 17:34","pubTimestamp":1785144840,"startTime":"0","endTime":"0","summary":"南财智讯7月27日电，诺诚健华（09969.HK）发布自愿公告，公司自主研发的TYK2变构抑制剂fadeucravacinib（ICP-488）用于治疗中重度斑块状银屑病的III期注册性临床试验成功达到主要终点，统计学显著且具临床意义，并同步达成多项次要终点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607273822201140.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607273822201140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688428","BK1574","09969","BK1161","BK4134","III","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653403937","title":"百利天恒：伦康依隆妥单抗两项III期临床完成首例入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2653403937","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653403937?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 20:00","pubTimestamp":1784808000,"startTime":"0","endTime":"0","summary":"7月23日，百利天恒（688506）发布公告，公司自主研发的全球首创EGFR×HER3双抗ADC伦康依隆妥单抗/宜泽康（BL-B01D1/iza-bren）两项III期临床试验于近日分别完成首例受试者入组，涉及适应症为经内分泌治疗失败的晚期HR+HER2-乳腺癌和含铂化疗失败的局部晚期或转移性胆道癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233819152061.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233819152061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688506","91194","III","02615","BK0239","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百济神州/安进 FIC 双抗，皮下制剂进入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0868494617.USD","688235","IBB","ONC","PBE","LU1719994722.HKD","LU1251922891.USD","PJP","LU1770034418.SGD","LU0058720904.USD","LU1983299246.USD","LU0320765992.SGD","III","SG9999001440.SGD","KURE","LU0307460666.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU2242652126.USD","LU1571399168.USD","BK1583","BK1500","BBH","LU0588546209.SGD","IE0009355771.USD","BK1588","BK4588","BK4599","06160","IBBQ","IE0002141913.USD","BK4534","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2112291526.USD","BK4139","LU1303224171.USD","AMGN","BIB","LU2242646821.SGD","LU0122379950.USD","LU2328871848.SGD","LU2468319806.SGD","BK4134","LU0289739699.SGD","BK4581","TBXU","BK4585","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744496","title":"百利天恒：伦康依隆妥单抗III期临床试验完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744496","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653744496?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 19:16","pubTimestamp":1784805390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4134","IBBJ","MDTX","BMED","IBBQ","III","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653746774","title":"远大医药(00512)：中药1.1类创新药GPN01360在中国开展的III期临床研究完成首例患者入组给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2653746774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653746774?lang=zh_cn&edition=fundamental","pubTime":"2026-07-23 18:20","pubTimestamp":1784802025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，远大医药 发布公告，近日，本集团用于治疗抑郁症的中药创新药GPN01360在中国开展的 III 期临床研究完成了首例患者入组给药。GPN01360 是一款用于治疗抑郁症的1.1类中药创新药，系国家“重大新药创制”专项重点支持研发的中药创新成果。因此，抑郁症的治疗仍存在较大未满足的临床需求，本集团的GPN01360有望为临床提供一种全新的治疗选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471489.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","BK1161","00512","MEDX","159992","III","06978","BK1191","BK1574","IBBQ","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653187205","title":"Devonian获加拿大卫生部批准，启动Thykamine小儿特应性皮炎II/III期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2653187205","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653187205?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 22:21","pubTimestamp":1784643660,"startTime":"0","endTime":"0","summary":"Devonian Health Group7月21日宣布，已获得加拿大卫生部的临床试验申请授权，将启动PUR 0110乳膏治疗小儿轻中度特应性皮炎的II/III期临床研究。此次儿科项目基于此前成人II期试验取得的积极结果，该结果已发表于同行评议期刊《Journal of Drugs in Dermatology》，显示Thykamine乳膏在成人轻中度特应性皮炎中具有统计学显著的疗效和良好的安全性。特应性皮炎是全球最常见的儿童慢性炎症皮肤病之一，约60%患儿在一岁内发病，85%在五岁前患病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-21/doc-iniiqvau9122982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4134","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272674","title":"君实生物：特瑞普利单抗新适应症补充申请获受理 拓展至II-III期可切除非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272674","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653272674?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 19:42","pubTimestamp":1784634120,"startTime":"0","endTime":"0","summary":"7月21日，君实生物（688180/01877）发布公告，公司收到国家药品监督管理局核准签发的《受理通知书》，特瑞普利单抗联合含铂化疗围手术期治疗可切除II-III期非小细胞肺癌的补充申请获得受理。本次申请的适应症由可切除IIIA-IIIB期非小细胞肺癌扩展为可切除II-III期非小细胞肺癌。由于药品研发周期长，审批环节多，本次补充申请能否获得批准存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607213815805376.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607213815805376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK4134","01877","III","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652688822","title":"加科思-B(01167)：完成泛KRAS抑制剂JAB-23E73联合化疗用于KRAS突变胰腺癌一线 治疗之Ib/III期临床试验在中国的首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2652688822","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652688822?lang=zh_cn&edition=fundamental","pubTime":"2026-07-20 06:42","pubTimestamp":1784500970,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B 发布公告，本公司的泛KRAS抑制剂JAB-23E73联合白蛋白结合型紫杉醇及吉西他滨用于KRAS突变胰腺癌一线治疗之Ib/III期临床试验在中国完成首例患者给药。本项研究的启动依托此前公布在本公司2025年度年度报告中并仍在推进的I期临床试验所取得的喜人初步临床数据。KRAS突变在胰腺癌中发生率极高。本项研究正式启动，是JAB-23E73研发进程中的重要里程碑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","BK4134","01167","BK1161","BK1574","IBBQ","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652747170","title":"午评：创指低开低走大跌4.71% 下跌个股超4300只","url":"https://stock-news.laohu8.com/highlight/detail?id=2652747170","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652747170?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 12:16","pubTimestamp":1784261771,"startTime":"0","endTime":"0","summary":"　　7月17日消息，市场低开低走，创指跌超4%，深成指跌超3%。下跌方面，医药板块集体调整，百诚医药、昭衍新药跌停；存储芯片板块延续跌势，香农芯创、佰维存储、江波龙等多股跌超10%，德明利连续第三日跌停；算力硬件股集体下挫，长光华芯领跌，中际旭创跌超10%。总体来看，两市个股呈普跌态势，下跌个股超4300只。　　截至午间收盘，沪指下跌1.64%，报3818.59点；深成指下跌3.70%，报13953.26点；创业板指下跌4.71%，报3518.65点。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/17/20260717154016.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/17/20260717154016.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangceping/20260717/32310306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LOFF","BK4089","SPCH","SPAL","SSPC","SPCG","SPCM","SPAX","SPCU","LU1861215975.USD","SPCX","III","SPCF","SNK","SPCQ","LU1861220033.SGD","LU2290526834.HKD","LU2360107168.USD","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651442713","title":"中国电信云网发展部和政企信息服务事业群总经理调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2651442713","media":"人民邮电报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651442713?lang=zh_cn&edition=fundamental","pubTime":"2026-07-16 20:57","pubTimestamp":1784206620,"startTime":"0","endTime":"0","summary":"记者获悉，潘天舒任中国电信集团有限公司云网发展部（国际部）总经理。潘天舒曾任中国电信集团有限公司政企信息服务事业群总经理。董涛任中国电信集团有限公司政企信息服务事业群总经理。董涛曾任中国电信广西分公司总经理、中国电信江苏分公司总经理、中国电信集团有限公司云网发展部（国际部）总经理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607163809284186.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607163809284186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00728","HK0000352291.HKD","LU0039217434.USD","BK1506","HK0000352382.USD","BK0261","BK1536","HK0000288784.HKD","BK1610","SGXZ49509284.SGD","BK4134","BK1133","HK0000286598.CNH","601728","SGXZ81163826.USD","BK1589","III","HK0000288743.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651246129","title":"科伦博泰TROP2 ADC实现“全球首个”：PD-L1阴性一线NSCLC III期达PFS主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2651246129","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651246129?lang=zh_cn&edition=fundamental","pubTime":"2026-07-15 22:38","pubTimestamp":1784126286,"startTime":"0","endTime":"0","summary":"7月15日早间，科伦博泰（HK06990，股价536.50港元，市值1282.36亿港元）宣布其TROP2ADC药物芦康沙妥珠单抗（佳泰莱?）联合帕博利珠单抗（可瑞达?）一线治疗PD-L1阴性非鳞状非小细胞肺癌的III期研究（OptiTROP-Lung06）在期中分析中达到无进展生存期主要终点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807804934.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807804934.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1169589451.USD","BK4080","ADC","NETL","BK4023","PD","BK4134","BK4195","LU1169590202.USD","BK4231","III","PFS","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":166,"code":"91000000","status":"200"}]}}